James C. Wei

Hsueh Shih Road
Taitung, TNQ 40402, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 663 publications

Maternal Autoimmune Diseases and Offspring Structural Congenital Heart Disease: A Nationwide Population-Based Cohort Study.

Maternal Autoimmune Diseases and Offspring Structural Congenital Heart Disease: A Nationwide Population-Based Cohort Study.

Journal: Journal of the American Heart Association

Published: August 07, 2026

Difficult-To-Manage Axial Spondyloarthritis: Bridging Consensus Definitions and Real-World Practice.

Difficult-To-Manage Axial Spondyloarthritis: Bridging Consensus Definitions and Real-World Practice.

Journal: International journal of rheumatic diseases

Published: July 27, 2026

Repurposing Denosumab for Knee Osteoarthritis: A Real-World Signal That Now Needs a Trial.

Repurposing Denosumab for Knee Osteoarthritis: A Real-World Signal That Now Needs a Trial.

Journal: International journal of rheumatic diseases

Published: July 22, 2026

Comparable 1-year effectiveness of tezepelumab and dupilumab after anti-IL-5/IL-5Rα biologic failure in severe asthma.

Comparable 1-year effectiveness of tezepelumab and dupilumab after anti-IL-5/IL-5Rα biologic failure in severe asthma.

Journal: European journal of internal medicine

Published: June 23, 2026

Bridging the Gap in Hydroxychloroquine Monitoring for Systemic Lupus Erythematosus: Evidence, Limitations, and Future Directions.

Bridging the Gap in Hydroxychloroquine Monitoring for Systemic Lupus Erythematosus: Evidence, Limitations, and Future Directions.

Journal: International journal of rheumatic diseases

Published: June 15, 2026

Beyond Inflammation: Breaking the Vicious Cycle of Matrix Stiffness and Mechanotransduction in Systemic Sclerosis.

Beyond Inflammation: Breaking the Vicious Cycle of Matrix Stiffness and Mechanotransduction in Systemic Sclerosis.

Journal: International journal of rheumatic diseases

Published: May 26, 2026

Antigen-Specific Tolerization in Rheumatoid Arthritis: Evaluating the Translational Potential of hPAD4 Plasmid Therapy.

Antigen-Specific Tolerization in Rheumatoid Arthritis: Evaluating the Translational Potential of hPAD4 Plasmid Therapy.

Journal: International journal of rheumatic diseases

Published: May 25, 2026

Comparative Neuropsychiatric Outcomes of JAK Inhibitors, Dupilumab, and Conventional Immunosuppressants in Atopic Dermatitis: A Real-World Cohort Study.

Comparative Neuropsychiatric Outcomes of JAK Inhibitors, Dupilumab, and Conventional Immunosuppressants in Atopic Dermatitis: A Real-World Cohort Study.

Journal: Biomedicines

Published: May 17, 2026

Dietary Patterns as Potential Immune-Metabolic Modifiers of Rheumatoid Arthritis Risk: Evidence and Priorities for Prevention Research.

Dietary Patterns as Potential Immune-Metabolic Modifiers of Rheumatoid Arthritis Risk: Evidence and Priorities for Prevention Research.

Journal: International journal of rheumatic diseases

Published: May 11, 2026

Sequential Switching Versus Combinatorial Blockade: Navigating the Safety-Efficacy Balance of Biologics in SLE.

Sequential Switching Versus Combinatorial Blockade: Navigating the Safety-Efficacy Balance of Biologics in SLE.

Journal: International journal of rheumatic diseases

Published: May 09, 2026

Comparative Real-World Outcomes of OnabotulinumtoxinA and CGRP Monoclonal Antibodies in Chronic Migraine.

Comparative Real-World Outcomes of OnabotulinumtoxinA and CGRP Monoclonal Antibodies in Chronic Migraine.

Journal: Journal of clinical medicine

Published: May 07, 2026

The association between SGLT2 inhibitors and rheumatoid arthritis risk in type 2 diabetes: findings from large-scale emulated target trials.

The association between SGLT2 inhibitors and rheumatoid arthritis risk in type 2 diabetes: findings from large-scale emulated target trials.

Journal: Frontiers in immunology

Published: April 28, 2026

Showing 1-12 of 663

Last Updated: 09/26/2026